2.4.0.8013 - Disclosure - Goodwilltruefalsefalse1false falsefalseContext_FYE__30-Jun-2013http://www.sec.gov/CIK0001362718duration2012-07-01T00:00:002013-06-30T00:00:001true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Intangible Assets and Goodwill [Abstract]2false 2us-gaap_GoodwillDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-variant: small-caps; font-weight: bold; display: inline;">Note 6 &#8211; Goodwill</font></div> <div style="display: block; text-indent: 0pt;">&#160;</div> <div align="justify" style="margin-left: 27pt; display: block; margin-right: 14.4pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On November 30, 2012, Chengdu Tianyin completed its acquisition of 100% equity interest in Sichuan Hengshuo for $210,600. Goodwill, which is equal to the excess of cost over the fair value of assets acquired, has been recorded in conjunction with the acquisition. Goodwill is accounted for in accordance with ASC 350 (formerly SFAS 142). The purchase price of $210,600 was assigned to goodwill as the net assets of HSP were minimum at the&#160;date of acquisition.</font></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for goodwill.No definition available.false0GOODWILLfalseGoodwillUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.tianyinpharma.com/role/Goodwill12